Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
Timofei S Zatsepin,1–3 Yuri V Kotelevtsev,1 Victor Koteliansky1,2 1Center of Functional Genomics, Skolkovo Institute of Science and Technology, 2Department of Chemistry, Lomonosov Moscow State University, 3Production Department, Central Research Institute of Epidemiology, Moscow, Russia...
Guardado en:
Autores principales: | Zatsepin TS, Kotelevtsev YV, Koteliansky V |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de001ee4390b43549ac852fcfb30b525 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
por: Javad Khanali, et al.
Publicado: (2021) -
Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells
por: Zhou Z, et al.
Publicado: (2017) -
A Lipid-Coated Nanoconstruct Composed of Gold Nanoparticles Noncovalently Coated with Small Interfering RNA: Preparation, Purification and Characterization
por: Anna V. Epanchintseva, et al.
Publicado: (2021) -
Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia Y, et al.
Publicado: (2017) -
The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction
por: Cai W, et al.
Publicado: (2018)